Cargando…
Metadherin regulates epithelial–mesenchymal transition in carcinoma
Metadherin (MTDH) was first identified in primary human fetal astrocytes exposed to HIV-1 in 2002 and then recognized as an important oncogene mediating tumorigenesis, progression, invasiveness, and metastasis of carcinomas. Epithelial–mesenchymal transition (EMT) is a vital process in embryonic dev...
Autores principales: | Wang, Zhao, Tang, Zheng-yan, Yin, Zhuo, Wei, Yong-bao, Liu, Long-fei, Yan, Bin, Zhou, Ke-qin, Nian, Ye-qi, Gao, Yun-liang, Yang, Jin-rui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844438/ https://www.ncbi.nlm.nih.gov/pubmed/27143938 http://dx.doi.org/10.2147/OTT.S104556 |
Ejemplares similares
-
Metadherin Promotes Malignant Phenotypes And Induces Beta-Catenin Nuclear Translocation And Epithelial–Mesenchymal Transition In Gastric Cancer
por: Feng, Di, et al.
Publicado: (2019) -
Repression of metadherin inhibits biological behavior of prostate cancer cells and enhances their sensitivity to cisplatin
por: WEI, YONG-BAO, et al.
Publicado: (2015) -
Circular RNA Circ-03955 Promotes Epithelial-Mesenchymal Transition in Osteosarcoma by Regulating miR-3662/Metadherin Pathway
por: Wang, Zhengguang, et al.
Publicado: (2020) -
Metadherin regulates actin cytoskeletal remodeling and enhances human gastric cancer metastasis via epithelial-mesenchymal transition
por: Du, Yaqiong, et al.
Publicado: (2017) -
miR-217-5p suppresses epithelial-mesenchymal transition and the NF-κB signaling pathway in breast cancer via targeting of metadherin
por: Yang, Lixian, et al.
Publicado: (2022)